Three Times Weekly Symptom Screening for Children With Cancer
NCT04275102 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2025-05-15
Summary
This study will evaluate the feasibility of three times weekly symptom reporting by children using the SPARK platform for 8 weeks. SPARK is a web-based application that promotes symptom screening for children receiving cancer therapies and enables access to clinical practice guidelines for symptom management. Newly diagnosed and relapsed patients with cancer will be enrolled. Children and/or their guardian will be prompted to complete symptom screening three times weekly via SPARK with corresponding feedback sent to their healthcare providers with each completed assessment. Symptom reports will contain links to clinical practice guidelines for symptom management. Active intervention will last for 8 weeks starting from the date of enrollment.
Conditions
- Cancer
- Relapsed Cancer
Interventions
- OTHER
-
SPARK
Prompt to complete symptom screening three times weekly via SPARK with corresponding feedback sent to healthcare providers with each completed assessment.
Sponsors & Collaborators
-
The Hospital for Sick Children
lead OTHER
Principal Investigators
-
Lillian Sung, MD, PhD · The Hospital for Sick Children
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 2 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-08-01
- Primary Completion
- 2025-11-29
- Completion
- 2025-11-29
Countries
- Canada
Study Locations
More Related Trials
-
Fenretinide in Treating Children With Solid Tumors
NCT00003191 ·Status: COMPLETED ·Phase: PHASE1
-
Perifosine With Temsirolimus for Recurrent Pediatric Solid Tumors
NCT01049841 ·Status: COMPLETED ·Phase: PHASE1
-
Ex Vivo Drug Sensitivity Testing and Mutation Profiling
NCT03860376 ·Status: COMPLETED
-
Chemotherapy in Treating Children With Relapsed Acute Leukemia, Acute Myeloid Leukemia, or Blastic Phase Chronic Myelogenous Leukemia
NCT00003735 ·Status: COMPLETED ·Phase: PHASE2
-
The PediQUEST Response Intervention Study
NCT03408314 ·Status: COMPLETED ·Phase: NA
-
A Study of SGT-53 in Children With Refractory or Recurrent Solid Tumors
NCT02354547 ·Status: SUSPENDED ·Phase: PHASE1
-
Sirolimus With Cyclophosphamide and Topotecan for Pediatric/Adolescent Relapsed and Refractory Solid Tumors
NCT01670175 ·Status: COMPLETED ·Phase: PHASE1
-
Individualized High Dose Methotrexate to Treat Cancer in Children Who Have a Significant Risk for Side Effects to Methotrexate
NCT02076997 ·Status: COMPLETED ·Phase: NA
-
KEYS to Succeed: Cognitive and Academic Intervention Program for Children and Adolescents Surviving Cancer
NCT02573441 ·Status: COMPLETED ·Phase: NA
-
The PediQUEST Study: Evaluation of Pediatric Quality of Life and Evaluation of Symptoms Technology
NCT01838564 ·Status: COMPLETED ·Phase: NA
-
Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors
NCT02574728 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology
NCT02847130 ·Status: COMPLETED
-
Irinotecan in Treating Children With Refractory or Progressive Solid Tumors
NCT00016861 ·Status: COMPLETED ·Phase: PHASE1
-
Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor
NCT00003273 ·Status: WITHDRAWN ·Phase: PHASE2
-
Pilot Study of Perindopril in Childhood Cancer Survivors
NCT01948232 ·Status: WITHDRAWN ·Phase: PHASE2
-
Topotecan in Treating Children With Refractory Leukemia
NCT00002705 ·Status: COMPLETED ·Phase: PHASE1
-
High-Intensity Parent Intervention Program in Improving Learning and School Functioning in Latino Children With Acute Leukemia or Lymphoblastic Lymphoma
NCT03178617 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma
NCT00017368 ·Status: COMPLETED ·Phase: PHASE2
-
Bright Ideas - CIN Feasibility Study
NCT04929899 ·Status: RECRUITING ·Phase: NA
-
Chemotherapy in Treating Children With Recurrent or Refractory Sarcomas
NCT00003745 ·Status: COMPLETED ·Phase: PHASE2
-
Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors With Sorafenib in Combination With Irinotecan
NCT02747537 ·Status: WITHDRAWN ·Phase: PHASE2
-
Study of @neWorld: A Virtual Community for Children With Cancer
NCT00070421 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Data Collection of Normal Tissue Toxicity for Proton Therapy for Pediatrics
NCT01502150 ·Status: UNKNOWN
-
Preventative Skin Care for Children Undergoing Targeted CNS Tumor Therapy
NCT04479514 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors
NCT00003141 ·Status: COMPLETED ·Phase: PHASE1